Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Study on the prediction model of liver cancer based on chronic liver disease and the related molecular mechanism Xiaojing Zhang; Xinye Chen;

Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans Siyu Fu; Dhamina Karim; Jhon Prieto; Domingo Balderramo; Javier Diaz Ferrer; Angelo Z. Mattos; Marco Arrese; Enrique Carrera; Jeffrey Oliveira; Jose D. Debes; Andre Boonstra;